{"nct_id":"NCT00263653","title":"Safety, Reactogenicity & Immunogenicity Study to Evaluate a Booster Dose of GSK Biologicals' Hib-MenC Given With Priorix™ in Toddlers (13-14 m) Primed With 3 Doses of Hib and MenC-CRM197","status":"COMPLETED","status_verified_date":"2016-09","start_date":"2005-03","start_date_type":null,"primary_completion_date":"2005-03","primary_completion_date_type":"ACTUAL","completion_date":"2005-09","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GSK"]}